Molecular biomarker in prostate cancer: the role of CpG island hypermethylation
- PMID: 15548435
- DOI: 10.1016/j.eururo.2004.07.022
Molecular biomarker in prostate cancer: the role of CpG island hypermethylation
Abstract
CpG island hypermethylation may be one of the earliest somatic genome alterations to occur during the development of multiple cancers. Recently, aberrant methylation patterns for different tumors have been reported. We present a comprehensive review of the literature describing the role of CpG island hypermethylation of DNA from prostatic tissue and bodily fluids from men with prostate cancer. We reviewed the literature to evaluate CpG island hypermethylation in tissue and bodily fluids of men with primary and metastatic prostate cancer. Additionally, we reviewed the literature with respect to CpG island hypermethylation patterns in other urological malignancies. Using modern analytic methods, CpG island hypermethylation detection can be achieved. In men with prostate cancer, correlations between specific gene regulatory region hypermethylation analyses and Gleason score, pathologic stage and tumor recurrence have been demonstrated. CpG island hypermethylation may serve as a useful molecular biomarker for the detection and diagnosis of patients with prostate cancer.
Similar articles
-
GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.J Cell Biochem. 2004 Feb 15;91(3):540-52. doi: 10.1002/jcb.10740. J Cell Biochem. 2004. PMID: 14755684 Review.
-
Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.Clin Cancer Res. 2005 Jun 1;11(11):4037-43. doi: 10.1158/1078-0432.CCR-04-2446. Clin Cancer Res. 2005. PMID: 15930338
-
Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.J Pathol. 2004 Feb;202(2):233-40. doi: 10.1002/path.1503. J Pathol. 2004. PMID: 14743506
-
Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.Cancer Res. 2001 Dec 15;61(24):8611-6. Cancer Res. 2001. PMID: 11751372
-
[GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer].Urologe A. 2004 May;43(5):573-9. doi: 10.1007/s00120-004-0540-7. Urologe A. 2004. PMID: 15029477 Review. German.
Cited by
-
Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review.Cancers (Basel). 2024 Jan 25;16(3):523. doi: 10.3390/cancers16030523. Cancers (Basel). 2024. PMID: 38339274 Free PMC article. Review.
-
Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.PLoS One. 2014 Mar 24;9(3):e92815. doi: 10.1371/journal.pone.0092815. eCollection 2014. PLoS One. 2014. PMID: 24664224 Free PMC article. Clinical Trial.
-
Disparities in prostate cancer incidence and mortality rates: Solvable or not?Prostate. 2020 Jan;80(1):3-16. doi: 10.1002/pros.23923. Epub 2019 Nov 8. Prostate. 2020. PMID: 31702061 Free PMC article. Review.
-
Epigenetic regulation of the expression of genes involved in steroid hormone biosynthesis and action.Steroids. 2010 Jul;75(7):467-76. doi: 10.1016/j.steroids.2010.02.004. Epub 2010 Feb 13. Steroids. 2010. PMID: 20156469 Free PMC article. Review.
-
Characterization of autoimmune inflammation induced prostate stem cell expansion.Prostate. 2015 Oct;75(14):1620-31. doi: 10.1002/pros.23043. Epub 2015 Jul 14. Prostate. 2015. PMID: 26174474 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical